OQS
MDGL icon

Occudo Quantitative Strategies’s Madrigal Pharmaceuticals MDGL Stock Holding History

Occudo Quantitative Strategies’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,719
Closed -$397K – 1038
2023
Q3 		$397K Buy
+2,719
New +$512K 0.05% 570
2022
Q4 		– Sell
-5,789
Closed -$376K – 1208
2022
Q3 		$376K Buy
5,789
+2,444
+73% +$170K 0.03% 768
2022
Q2 		$239K Buy
+3,345
New +$246K 0.02% 857
2021
Q4 		– Sell
-4,564
Closed -$364K – 1175
2021
Q3 		$364K Sell
4,564
-6,914
-60% -$597K 0.04% 662
2021
Q2 		$1.12M Buy
11,478
+3,943
+52% +$467K 0.17% 185
2021
Q1 		$881K Sell
7,535
-3,053
-29% -$356K 0.19% 157
2020
Q4 		$1.18M Buy
+10,588
New +$1.29M 0.37% 43

Other funds holding MDGL

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Occudo Quantitative Strategies's MDGL Position: Q4 2023 in Review

Occudo Quantitative Strategies sold out of Madrigal Pharmaceuticals (MDGL) in Q4 2023, closing a stake of 2,719 shares — an estimated $397K sold.

Occudo Quantitative Strategies first reported a position in MDGL in Q4 2020 and held it in 7 quarters. The position peaked at $1.18M in Q4 2020. 226 funds tracked by Wall St. Rank hold MDGL as of Q4 2023.

  • Occudo Quantitative Strategies reported no remaining Madrigal Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 2,719 Madrigal Pharmaceuticals shares in Q4 2023, an estimated $397K.
  • Occudo Quantitative Strategies first reported a position in Madrigal Pharmaceuticals in Q4 2020 and held it in 7 quarters.
  • Occudo Quantitative Strategies's Madrigal Pharmaceuticals position peaked at $1.18M in Q4 2020.
  • 226 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.